These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 16061064)
1. Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes? Baskin S; Neher JO; Dodson S; Hoffman R J Fam Pract; 2005 Aug; 54(8):723-4. PubMed ID: 16061064 [No Abstract] [Full Text] [Related]
2. Avandia in perspective. Comarow A US News World Rep; 2007 Oct; 143(11):71. PubMed ID: 17957906 [No Abstract] [Full Text] [Related]
3. Pioglitazone-induced heart failure despite normal left ventricular function. Shah M; Kolandaivelu A; Fearon WF Am J Med; 2004 Dec; 117(12):973-4. PubMed ID: 15629744 [No Abstract] [Full Text] [Related]
4. Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime. Leier CV; Haas GJ J Am Coll Cardiol; 2007 Jul; 50(1):37-9. PubMed ID: 17601543 [No Abstract] [Full Text] [Related]
5. Thiazolidinediones and heart failure: a teleo-analysis. Singh S; Loke YK; Furberg CD Diabetes Care; 2007 Aug; 30(8):2148-53. PubMed ID: 17536074 [TBL] [Abstract][Full Text] [Related]
6. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs? Buckingham RE; Hanna A Diabetes Obes Metab; 2008 Apr; 10(4):312-28. PubMed ID: 18333890 [TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits. Patel RR Cardiol Rev; 2009; 17(3):132-5. PubMed ID: 19384087 [TBL] [Abstract][Full Text] [Related]
8. [Heart failure while taking glitazones--what do we know today?]. Halbritter R Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1488; author reply 1488. PubMed ID: 19572255 [No Abstract] [Full Text] [Related]
9. [Heart failure with thiazolidinedione treatment: what do we know today?]. Erdmann E Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858 [TBL] [Abstract][Full Text] [Related]
10. [Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials]. De Flines J; Scheen AJ Rev Med Suisse; 2007 Aug; 3(122):1876, 1878-83. PubMed ID: 17896661 [TBL] [Abstract][Full Text] [Related]
11. Research profile. Is there a link? TZDs and congestive heart failure. Andrew Karter, PhD. Kordella T Diabetes Forecast; 2004 Jun; 57(6):98-100. PubMed ID: 15195634 [No Abstract] [Full Text] [Related]
12. Thiazolidinediones in type 2 diabetes: a cardiology perspective. Khanderia U; Pop-Busui R; Eagle KA Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014 [TBL] [Abstract][Full Text] [Related]
13. The rough road for rosiglitazone. Goldfine AB Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):113-7. PubMed ID: 18316944 [TBL] [Abstract][Full Text] [Related]
14. The value equation for rosiglitazone and pioglitazone in older persons. Zarowitz BJ Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172 [No Abstract] [Full Text] [Related]
15. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus. Irons BK; Greene RS; Mazzolini TA; Edwards KL; Sleeper RB Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323 [TBL] [Abstract][Full Text] [Related]
16. N-3 polyunsaturated fatty acids and statins in heart failure. Parashar A Lancet; 2009 Jan; 373(9661):379; author reply 380-1. PubMed ID: 19186266 [No Abstract] [Full Text] [Related]
17. Diabetes medicine update. Old dogs, new tricks. Nakamoto M Diabetes Self Manag; 2003; 20(1):14-5. PubMed ID: 12632553 [No Abstract] [Full Text] [Related]
18. Thiazolidinediones in heart failure: slippery when wet. Khush KK J Card Fail; 2008 Aug; 14(6):453-5. PubMed ID: 18672191 [No Abstract] [Full Text] [Related]
19. Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure. Erdmann E; Wilcox RG Eur Heart J; 2008 Jan; 29(1):12-20. PubMed ID: 18167366 [TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus. Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):785-96. PubMed ID: 21671441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]